The Discounted Cash Flow (DCF) valuation of Epizyme Inc (EPZM) is (485.52) USD. With the latest stock price at 1.47 USD, the upside of Epizyme Inc based on DCF is -33128.3%.
Based on the latest price of 1.47 USD and our DCF valuation, Epizyme Inc (EPZM) is a sell. selling EPZM stocks now will result in a potential gain of 33128.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 7.4% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,081.51) - (317.88) | (485.52) |
| Upside | -73672.2% - -21724.7% | -33128.3% |